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Abstract
Osteoarthritis (OA) is a common disease that has a definite genetic component. Only a few OA susceptibility genes that
have definite functional evidence and replication of association have been reported, however. Through a genome-wide
association study and a replication using a total of ,4,800 Japanese subjects, we identified two single nucleotide
polymorphisms (SNPs) (rs7775228 and rs10947262) associated with susceptibility to knee OA. The two SNPs were in a region
containing HLA class II/III genes and their association reached genome-wide significance (combined P=2.43610
28 for
rs7775228 and 6.73610
28 for rs10947262). Our results suggest that immunologic mechanism is implicated in the etiology of
OA.
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Introduction
We are living in the ‘‘Bone and Joint Decade’’ (http://www.
boneandjointdecade.org/). As the WHO initiative shows, bone
and joint diseases are serious problems all over the world, putting
us under severe medical, economical and social burden.
Osteoarthritis (OA; MIM 165720) is one of the most common
diseases among them. OA affects synovial joints of all over the
body, mainly knee, hip, hand and spine. OA is characterized by
progressive loss of articular cartilage and, often, proliferation of
synovium and bone, which lead to pain, loss of joint function and
disability. More than tens of millions patients in the world are
suffering from this non-lethal, but intractable disease, and the
number is relentlessly increasing; however, its etiological picture
remains unclear and we have no fundamental treatment for it.
OA is a polygenic disease. Both environmental and genetic
factors contribute to its etiology and pathogenesis [1]. To
understand its genetic factor, identification of its susceptibility
gene(s) must be the first step. Many OA susceptibility genes
identified by candidate-gene association studies have been
reported, but only a few have supporting functional evidence
and replication of the results in different populations [1,2]. Large-
scale association studies including the genome-wide association
study (GWAS) using high-density single nucleotide polymorphisms
(SNPs) have been reported by a few groups in Asia and Europe
[3–6], but only a gene fulfilled genome-wide significance level [2].
The genetic basis of OA susceptibility remains largely unchar-
acterized. To identify OA susceptibility gene(s), we conducted a
GWAS for knee OA and identified two SNPs with genome-wide
significance level.
Methods
Samples
Characteristics of each cohort group are shown in Table 1. Case
samples of GWAS for the Japanese population were obtained from
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Knee OA was diagnosed on the basis of clinical and radiographic
findings using previously described criteria [5,7]. Rheumatoid
arthritis (RA) and polyarthritis associated with autoimmune
diseases were excluded, as were secondary OA due to crystal
deposition (gout and pseudogout), posttraumatic OA and infec-
tion-induced OA. Patients who had clinical and radiographic
findings suggestive of skeletal dysplasias, including overt short
stature, multiple symmetric involvements of epiphyses and a
definitely positive Mendelian family history were also excluded
from the study. The control groups consisted of 3,396 individuals
that were registered in the Leading Project for Personalized
Medicine in the Ministry of Education, Culture, Sports, Science
and Technology, Japan as the subjects with diseases unrelated to
OA and the volunteers in the Osaka-Midosuji Rotary Club,
Osaka, Japan [8]. For replication study, we recruited population-
based cohorts from inhabitants of Odai and Minami-ise town
(previously Miyagawa village and Nansei town, respectively in the
Mie prefecture in Japan) [9]. The Spanish and Greek knee OA
and control populations were recruited as described previously
from the Hospital Clinico de Santiago, the Departments of Biology
and Genetics and of Orthopaedics, University of Thessaly and the
Institute of Musculoskeletal Sciences [10]. All the participants
provided written informed consent. This research project was
approved by the ethical committees at Center for Genomic
Medicine (formerly, SNP Research Center), RIKEN and the
participating institutions.
SNP genotyping
For the GWAS, we genotyped 906 patients with OA and 3,396
controls using Illumina HumanHap550v3 Genotyping BeadChip.
After excluding seven cases with call rate of ,0.98, we applied SNP
QC (call rate of $0.99 in both cases and controls and P value of
Hardy-Weinberg equilibrium test of $1.0610
26 in controls). Finally,
459,393 SNPs on autosomal chromosomes passed the QC filters and
were further analyzed. Among the SNPs analyzed in the GWAS, we
selected top 15 SNPs showing the smallest P values (P,1610
25)f o r
the replication study using an independent 514 Japanese subjects
from a resident cohort. SNPs with minor allele frequency of #0.1 in
both case and control samples were excluded from the further
analysis. In the replication analysis, we genotyped SNPs using the
multiplex PCR-based invader assay (Third Wave Technologies) or
by direct sequencing of PCR products using ABI 3700 DNA
analyzers (Applied Biosystems), or by SNaPshot Multiplex System
(Applied Biosystems) according to manufacturers’ protocols.
Statistical analysis
In the GWAS and replication analyses, we applied Fisher’s
exact test to two-by-two contingency table in three genetic models:
an allele frequency model, a dominant-effect model, and a
recessive-effect model. We conducted the meta-analysis using the
Mantel-Haenszel method. We examined heterogeneity among
studies by using the Breslow-Day test. Significance levels after the
Bonferroni correction for multiple testing were P=1.09610
27
(0.05/459,393). Age, gender- and BMI-adjusted odds ratios were
obtained by logistic regression analysis [11]. Odds ratios and
confidence intervals were calculated using the risk allele as a
reference. We analyzed the haplotype association using Haploview
software [12]. We conducted a principal component analysis to
detect population stratification [13].
Software
For general statistical analysis, we used R statistical environment
version 2.6.1 or Microsoft Excel. Drawing the LD map, estimation
of haplotype frequencies and analysis of haplotype association
were performed by Haploview software.
Results
To identify genetic variants that determine OA susceptibility,
we conducted a GWAS in Japanese knee OA. We examined 906
individuals with knee OA and 3,396 control individuals (Table 1)
using Illumina HumanHap550v3 Genotyping BeadChip. After
confirming the data quality, we compared the results of 459,393
SNPs between cases and controls by Fisher’s exact test for three
genetic models: allelic, dominant or recessive (Figure 1). Fifteen
Table 1. Basal characteristics of the subjects.
Cohort Source Platform
Number of
samples Nationality Female (%)
Age
(mean +/2 sd)
BMI
(mean +/2 sd)
Severity
a
(% severe OA)
GWAS
knee OA RIKEN Illumina HumanHap550 899 Japanese 759 (84.4) 71.6+/27.6 24.9+/23.6 76.5
control ORC+BioBank Japan Illumina HumanHap550 3,396 Japanese 1,491 (43.9) 52.5+/215.2 22.5+/23.7 –
Replication
Japanese
knee OA RIKEN Invader assay 167 Japanese 124 (74.3) 73.8+/26.1 24.5+/23.3 48.5
control RIKEN Invader assay 347 Japanese 223 (64.3) 65.9+/28.7 22.3+/22.7 –
European Caucasian
knee OA Santiago de Compostela SNaPshot 243 Spanish 197 (81.1) 68.0+/25.7 32.8+/24.8 ND
b
control Santiago de Compostela SNaPshot 426 Spanish 165 (38.7) 68.4+/29.1 28.3+/23.8 –
knee OA University of Thessaly SNaPshot 570 Greek 468 (82.1) 65.8+/28.7 29.1+/23.3 77.1
control University of Thessaly SNaPshot 645 Greek 417 (64.6) 59.5+/211.6 25.4+/23.7 –
OA: osteoarthritis, ORC: Osaka-Midosuji Rotary Club.
aKellegren-Laurence grade $3 was considered as severe OA.
bAll cases underwent TKR (total knee replacement) surgery.
doi:10.1371/journal.pone.0009723.t001
GWAS of Knee Osteoarthritis
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values (minimum P,1610
25) were next genotyped in an
independent set of 167 Japanese knee OA individuals and 347
Japanese controls from a resident cohort study. Through these
studies, only two SNPs, rs7775228 (combined P=2.43610
28;
OR=1.34; 95% CI=1.21–1.49) and rs10947262 (combined
Figure 1. Results of a genome-wide association study (–log10 P value plot). Each P value is the minimum of Fisher’s exact tests for three
models: dominant, recessive and allele frequency model.
doi:10.1371/journal.pone.0009723.g001
Table 2. Association of rs7775228 and rs10947262 with knee osteoarthritis.
SNP
(Nearest gene) Allele Population Minor allele Frequency
Case Control OR (95% CI)
a P
b Phet
c
rs7775228 C/T Japanese
(HLA-DQB1) GWAS 0.318 0.379 1.31 (1.18–1.47) 1.38 E-06
Replication 0.290 0.385 1.53 (1.15–2.02) 3.07 E-03
Combined
d 1.34 (1.21–1.49) 2.43 E-08 0.33
European Caucasian
Spanish 0.194 0.209 1.10 (0.83–1.45) 0.521
Greek 0.094 0.075 0.78 (0.58–1.03) 0.084
European combined
e 0.93 (0.76–1.13) 0.178 0.09
All combined
f – – 0.003
rs10947262 C/T Japanese
(BTNL2) GWAS 0.358 0.419 1.30 (1.16–1.44) 2.45 E-06
Replication 0.332 0.422 1.47 (1.12–1.93) 5.74 E-03
Combined
d 1.32 (1.19–1.46) 6.73 E-08 0.40
European Caucasian
Spanish 0.122 0.136 1.13 (0.81–1.59) 0.465
Greek 0.068 0.094 1.43 (1.06–1.92) 0.019
European combined
e 1.29 (1.03–1.61) 0.025 0.32
All combined
f 1.31 (1.20–1.44) 5.10 E-09 0.63
Odds ratios (ORs) and P values for the independence test were calculated by the Mantel-Haenszel method.
aOR of the risk allele from the two-by-two allele frequency table.
bP values of the Pearson’s x
2 test for the allele model.
cResults of the Breslow-Day test.
dMeta-analysis of Japanese studies.
eMeta-analysis of European studies.
fMeta-analysis of all studies.
doi:10.1371/journal.pone.0009723.t002
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28; OR=1.32; 95% CI=1.19–1.46) were significant
even after the Bonferroni correction for multiple testing
(P=1.09610
27) (Table 2). The two SNPs showing significant
associations are located within a 340-kb region within the HLA
locus, including BTNL2, HLA-DRA, HLA-DRB5, HLA-DRB1,
HLA-DQA1 and HLA-DQB1 (Figure 2). Although the HLA region
is known to show extensive linkage disequilibrium (LD) spanning
over 7 Mb, only SNPs in the 340-kb region showed strong
associations with OA (Figure 2), and SNPs outside of this region
did not have significant association.
Application of the Cochrane-Armitage test to all the tested
SNPs indicated that the genetic inflation factor lambda was
1.08 for GWAS (Figure 3), implying a low possibility of false
positive associations due to population stratification. We also
carried out age, gender- and BMI-adjusted analysis using a
logistic regression model, and confirmed similar association after
adjustment (data not shown). The principal component analysis
[13] revealed that there was no evidence for population
stratification between the two control groups used for the
GWAS (Figure S1).
To check the association of rs7775228 and rs10947262 in
different ethnic populations, we examined the association of the
SNPs with knee OA in two European Caucasian populations from
Greece and Spain. We genotyped a total of 813 OA and 1,071
control subjects (Table 1). We conducted the meta-analysis using
the Mantel-Haenszel method. The combined European results for
rs7775228 were not significant with OR (95%CI) of 0.93 (0.76–
1.13) (Table 2), while those for rs10947262 were supportive with
OR (95%CI) of 1.29 (1.03–1.61). rs10947262 showed replication
in the Greek population and the same trend in the Spanish
population (Table 2). A meta-analysis of the Japanese and two
European studies gave more significant association (combined
P=5.10610
29).
We estimated the pairwise LD indexes (D’ and r
2) between
rs7775228 and rs10947262 using the genotype data of Japanese
populations (GWAS and the replication study), and found that
they were in strong LD with each other (D’=0.82, r
2=0.56). They
formed two frequent haplotypes (Haplotype I and II; Table 3)
accounting for about 90% of all observed chromosomes. The
haplotypes were also significantly associated with knee OA;
Haplotype I, the most frequent haplotype was a risk haplotype
(P=1.48610
28; OR=1.33; 95% CI=1.20–1.46).
Discussion
We performed a GWAS followed by a replication in an
independent population using a total of ,4,800 Japanese subjects,
and identified two SNPs (rs7775228 and rs10947262) in the HLA
class II/III locus associated with susceptibility to knee OA. To our
knowledge, this study represents the first GWAS of OA with
extensive coverage (,550,000 markers) and definite genome-wide
significance even after Bonferroni’s correction, which is very
Figure 2. Case-control association analysis and linkage disequilibrium (LD) map of the HLA class II/III region of chromosome 6. (A)
The LD map based on D’ was drawn using HapMap data release 24 for the JPT population. (B) Genomic structure within the extended HLA-II/III
region. (C) Results of GWAS for osteoarthritis in Japanese population. The log10-transformed P values are plotted on the y axis.
doi:10.1371/journal.pone.0009723.g002
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confounding factors. Since two groups of controls were used in the
GWAS, we evaluated the possibility of genetic heterogeneity
between the two groups by a principal component analysis and
found it unlikely (Figure S1). Although there was large age
difference between the case and control groups of GWAS
(Table 1), significant association was observed after the age
adjustment.
In the NCBI genome database, rs7775228 and rs10947262
located between upstream region of HLA-DQA2 and HLA-DQB1,
and within the intron 1 of BTNL2, respectively (Figure 2). HLA-
DQA2 and HLA-DQB1 encode HLA-DQ a and b chains, which
belong to the HLA class II molecules. HLA class II molecules are
expressed in antigen presenting cells (B lymphocytes, dendritic
cells and macrophages) and play a central role in the immune
system by presenting peptides derived from extracellular proteins
[14]. The HLA-DQA2 protein is expressed, but at a very low level
in comparison with the HLA-DQA1 protein [15,16]. Moreover,
the HLA-DQA2 a chain does not dimerize with class II b chains
[16]. BTNL2 encodes butyrophilin-like 2, a member of butyr-
ophilin family that shares sequence homology with the B7 co-
stimulatory molecules. BTNL2 regulates T-cell activation through
unknown receptor, distinct from CD28 and CTLA-4 [17]. In
Japanese population, the haplotype association was more signif-
icant than those of respective SNPs (Tables 2 and 3). Therefore,
there may be hidden SNP(s) with a lower P value than rs7775228
and rs10947262, or the haplotype may be implicated in the OA
susceptibility. An association of sarcoidosis with rs2076530, a
coding SNP on exon 5 of the BTNL2 gene has been reported [18],
but the SNP was not in LD with rs10947262 (D’=0.11, r
2=0).
The 340-kb region of HLA locus, where the two SNPs are
located also includes HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-
DRB4, HLA-DRB5 and HLA-DQA1. HLA-DRA, HLA-DRB1/3/4/
5 and HLA-DQA1 encode HLA-DR a, b and HLA-DQ a chains,
which could also belong to the HLA class II molecules. HLA-DRB1
is present in all individuals. Allelic variants of HLA-DRB1 are
linked with either none or one of the genes HLA-DRB3, HLA-
DRB4 and HLA-DRB5 [19]. Among these genes, HLA-DRB1 is
strongly associated with RA. Some subtypes of HLA-DRB1 alleles,
such as *0101, *0401, and *0405, is associated with RA [20], but
not with generalized OA [21].
Although OA has generally been considered a non-inflammatory
disease, accumulating evidences suggest that this is not the case.
Inflammation involving activated T cells in the synovial membrane
of OA patients is well documented [22]. Recently, we identified a
genetic variant of EDG2 gene encoding lysophosphatidic acid
receptor associated with knee OA [23]. A GWAS has identified a
genetic variant of the PTGS2 gene encoding cyclooxygenase-2
involved in risk for knee OA [6]. These genetic associations of genes
such as EDG2 and PTGS2 underscore the potential role of
inflammatory pathways in the pathogenesis of knee OA.
Several studies have suggested associations of OA with HLA
class I and class II alleles. Study on generalized OA revealed
association with HLA A1-B8 in Caucasian [24] and with HLA-
Cw4 in Japanese [21]. An association of the HLA-DRB1*02
alleles with knee and hip OA was identified in a cohort of 106
patients [25]. Interestingly, chondrocyte, which are normally
HLA-DP, DQ and DR-negative, become positive for them in OA
[26,27], suggesting their function as antigen-presenting cells.
Cartilage fragments are mechanically shaved from the joint
surface and frequently found in the synovial membrane of OA
patients [28]. So, physical interaction between chondrocytes and T
cells is conceivable. Peripheral blood T cells from OA patients
show significantly higher proliferative responses to autologous
chondrocytes [27]. Our results further support the concept that
OA is an immunologic disorder.
Supporting Information
Figure S1 Principal component analysis of GWAS samples.
Samples in the GWAS and in HapMap database are analyzed by
a program of Smartpca [12], and plotted for the first (X axis) and
the second (Y axis) principal component (PC), respectively.
Found at: doi:10.1371/journal.pone.0009723.s001 (0.16 MB TIF)
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